The FDA just approved a first-of-its kind medication, meaning there is now a “complete, non-invasive option” for people with this common type of visual impairment.

The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1 ...

Age-related near vision loss has long been treated as an inevitable annoyance of getting older, a slow erosion of clarity ...

Health experts warn no single type of product can treat all kinds of eye diseases, refuting false social media advertisements ...

Eye drops for presbyopia represent a major opportunity for patients, but their reception by eye care professionals since the ...

Repeat administration under compassionate use was previously shown to be well tolerated and associated with full corneal healing by 3 months as well as significant visual acuity improvement from hand ...

Credit: Alcon. Access initiatives including a First Fill Free trial program and an ongoing copay support will be available for eligible patients. The active ingredient in Tryptyr is acoltremon, an ...

YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...